메뉴 건너뛰기




Volumn 61, Issue 3, 2003, Pages 251-258

Therapeutic drug monitoring of immunosuppressive drugs: Focus on mycophenolate mofetil and sirolimus measurement and on sampling of cyclosporine at C2;Suivi thérapeutique pharmacologique de l'acide mycophénolique, du sirolimus et de la ciclosporine au moyen du « C2 »

Author keywords

Cyclosporin; Immunosuppressive drug; Mycophenolate mofetil; Sirolimus; Therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

EID: 0038686882     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (34)
  • 1
    • 0034091294 scopus 로고    scopus 로고
    • Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs
    • Kahan BD, Welsh M, Urbauer DL, et al. Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs. J Am Soc Nephrol 2000 ; 11 : 1122-31.
    • (2000) J Am Soc Nephrol , vol.11 , pp. 1122-1131
    • Kahan, B.D.1    Welsh, M.2    Urbauer, D.L.3
  • 2
    • 0028824489 scopus 로고
    • Lake Louise consensus conference on cyclosporin monitoring in organ transplantation: Report of the consensus panel
    • Oellerich M, Armstrong VW, Kahan B, et al. Lake Louise consensus conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 1995 ; 17 : 642-54.
    • (1995) Ther Drug Monit , vol.17 , pp. 642-654
    • Oellerich, M.1    Armstrong, V.W.2    Kahan, B.3
  • 3
    • 0025148248 scopus 로고
    • Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine
    • Kahan BD, Shaw LM, Holt D, Grevel J, Johnston A. Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine. Clin Chem 1990 ; 36 : 1510-6.
    • (1990) Clin Chem , vol.36 , pp. 1510-1516
    • Kahan, B.D.1    Shaw, L.M.2    Holt, D.3    Grevel, J.4    Johnston, A.5
  • 4
    • 0032963830 scopus 로고    scopus 로고
    • Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: How specific is specific?
    • Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem 1999 ; 45 : 371-81.
    • (1999) Clin Chem , vol.45 , pp. 371-381
    • Steimer, W.1
  • 5
    • 0031712056 scopus 로고    scopus 로고
    • Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): A critical overview of performance characteristics and comparison with HPLC
    • Schutz E, Svinarov D, Shipkova M, et al. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem 1998 ; 44 : 2158-64.
    • (1998) Clin Chem , vol.44 , pp. 2158-2164
    • Schutz, E.1    Svinarov, D.2    Shipkova, M.3
  • 6
    • 0034046768 scopus 로고    scopus 로고
    • New approaches to cyclosporine monitoring raise further concerns about analytical techniques
    • Holt DW, Johnston A, Kahan BD, Morris RG, Oellerich M, Shaw LM. New approaches to cyclosporine monitoring raise further concerns about analytical techniques. Clin Chem 2000 ; 46 : 872-4.
    • (2000) Clin Chem , vol.46 , pp. 872-874
    • Holt, D.W.1    Johnston, A.2    Kahan, B.D.3    Morris, R.G.4    Oellerich, M.5    Shaw, L.M.6
  • 7
    • 0036146789 scopus 로고    scopus 로고
    • International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoring
    • Holt DW, Armstrong VW, Griesmacher A, Morris RG, Napoli KL, Shaw LM. International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoring. Ther Drug Monit 2002 ; 24 : 59-67.
    • (2002) Ther Drug Monit , vol.24 , pp. 59-67
    • Holt, D.W.1    Armstrong, V.W.2    Griesmacher, A.3    Morris, R.G.4    Napoli, K.L.5    Shaw, L.M.6
  • 8
    • 0033565808 scopus 로고    scopus 로고
    • Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation
    • Mahalati K, Belitsky P, Sketris I, West K, Panek R. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999 ; 68 : 55-62.
    • (1999) Transplantation , vol.68 , pp. 55-62
    • Mahalati, K.1    Belitsky, P.2    Sketris, I.3    West, K.4    Panek, R.5
  • 9
    • 0035086066 scopus 로고    scopus 로고
    • Approaching the therapeutic window for cyclosporine in kidney transplantation: A prospective study
    • Mahalati K, Belitsky P, West K, et al. Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 2001 ; 12 : 828-33.
    • (2001) J Am Soc Nephrol , vol.12 , pp. 828-833
    • Mahalati, K.1    Belitsky, P.2    West, K.3
  • 10
    • 0035960050 scopus 로고    scopus 로고
    • Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation
    • Canadian Néoral renal transplantation study group. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation. Transplantation 2001 ; 72 : 1024-32.
    • (2001) Transplantation , vol.72 , pp. 1024-1032
  • 11
    • 0035670894 scopus 로고    scopus 로고
    • C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients
    • Citterio F, Scata MC, Borzi MT, Pozzetto U, Castagneto M. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients. Transplant Proc 2001 ; 33 : 3133-6.
    • (2001) Transplant Proc , vol.33 , pp. 3133-3136
    • Citterio, F.1    Scata, M.C.2    Borzi, M.T.3    Pozzetto, U.4    Castagneto, M.5
  • 12
    • 0032573689 scopus 로고    scopus 로고
    • Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients
    • Cantarovich M, Barkun JS, Tchervenkov JI, Besner JG, Aspeslet L, Metrakos P. Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients. Transplantation 1998 ; 66 : 1621-7.
    • (1998) Transplantation , vol.66 , pp. 1621-1627
    • Cantarovich, M.1    Barkun, J.S.2    Tchervenkov, J.I.3    Besner, J.G.4    Aspeslet, L.5    Metrakos, P.6
  • 13
    • 0033134928 scopus 로고    scopus 로고
    • Relationship of pharmacokinetics to clinical outcomes
    • Levy GA. Relationship of pharmacokinetics to clinical outcomes. Transplant Proc 1999 ; 31 : 1654-8.
    • (1999) Transplant Proc , vol.31 , pp. 1654-1658
    • Levy, G.A.1
  • 14
    • 0031863345 scopus 로고    scopus 로고
    • Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy
    • Cantarovich M, Besner JG, Barkun JS, Elstein E, Loertscher R. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transplant 1998 ; 12 : 243-9.
    • (1998) Clin Transplant , vol.12 , pp. 243-249
    • Cantarovich, M.1    Besner, J.G.2    Barkun, J.S.3    Elstein, E.4    Loertscher, R.5
  • 15
    • 0033611084 scopus 로고    scopus 로고
    • Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients
    • Cantarovich M, Elstein E, de Varennes B, Barkun JS. Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 1999 ; 68 : 1839-42.
    • (1999) Transplantation , vol.68 , pp. 1839-1842
    • Cantarovich, M.1    Elstein, E.2    De Varennes, B.3    Barkun, J.S.4
  • 16
    • 0036150427 scopus 로고    scopus 로고
    • Two-hour cyclosporine concentration determination: An appropriate tool to monitor neoral therapy?
    • Oellerich M, Armstrong VW. Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy? Ther Drug Monit 2002 ; 24 : 40-6.
    • (2002) Ther Drug Monit , vol.24 , pp. 40-46
    • Oellerich, M.1    Armstrong, V.W.2
  • 18
    • 0030670814 scopus 로고    scopus 로고
    • Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings
    • Zucker K, Rosen A, Tsaroucha A, et al. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol 1997 ; 5 : 225-32.
    • (1997) Transpl Immunol , vol.5 , pp. 225-232
    • Zucker, K.1    Rosen, A.2    Tsaroucha, A.3
  • 19
    • 0034021381 scopus 로고    scopus 로고
    • Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A
    • Glanemann M, Klupp J, Langrehr JM, et al. Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A. Transplant Proc 2000 ; 32 : 522-3.
    • (2000) Transplant Proc , vol.32 , pp. 522-523
    • Glanemann, M.1    Klupp, J.2    Langrehr, J.M.3
  • 20
    • 0035139009 scopus 로고    scopus 로고
    • Mycophenolic acid plasma concentrations: Influence of comedication
    • Pou L, Brunet M, Cantarell C, et al. Mycophenolic acid plasma concentrations: influence of comedication. Ther Drug Monit 2001 ; 23 : 35-8.
    • (2001) Ther Drug Monit , vol.23 , pp. 35-38
    • Pou, L.1    Brunet, M.2    Cantarell, C.3
  • 21
    • 0032947542 scopus 로고    scopus 로고
    • Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring
    • Meiser BM, Pfeiffer M, Schmidt D, et al. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring. J Heart Lung Transplant 1999 ; 18 : 143-9.
    • (1999) J Heart Lung Transplant , vol.18 , pp. 143-149
    • Meiser, B.M.1    Pfeiffer, M.2    Schmidt, D.3
  • 22
    • 0033609476 scopus 로고    scopus 로고
    • A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation
    • van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1999 ; 68 : 261-6.
    • (1999) Transplantation , vol.68 , pp. 261-266
    • Van Gelder, T.1    Hilbrands, L.B.2    Vanrenterghem, Y.3
  • 23
    • 0035712708 scopus 로고    scopus 로고
    • Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy
    • Le Guellec C, Buchler M, Giraudeau B, et al. Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy. Eur J Clin Pharmacol 2002 ; 57 : 805-11.
    • (2002) Eur J Clin Pharmacol , vol.57 , pp. 805-811
    • Le Guellec, C.1    Buchler, M.2    Giraudeau, B.3
  • 24
    • 0034897144 scopus 로고    scopus 로고
    • Current issues in therapeutic drug monitoring of mycophenolic acid: Report of a roundtable discussion
    • Shaw LM, Holt DW, Oellerich M, Meiser B, van Gelder T. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit 2001 ; 23 : 305-15.
    • (2001) Ther Drug Monit , vol.23 , pp. 305-315
    • Shaw, L.M.1    Holt, D.W.2    Oellerich, M.3    Meiser, B.4    Van Gelder, T.5
  • 25
    • 0035116884 scopus 로고    scopus 로고
    • Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients
    • Shaw LM, Korecka M, DeNofrio D, Brayman KL. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Clin Biochem 2001 ; 34 : 17-22.
    • (2001) Clin Biochem , vol.34 , pp. 17-22
    • Shaw, L.M.1    Korecka, M.2    DeNofrio, D.3    Brayman, K.L.4
  • 26
    • 0033981118 scopus 로고    scopus 로고
    • Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation
    • Shaw LM, Kaplan B, DeNofrio D, Korecka M, Brayman KL. Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit 2000 ; 22 : 14-9.
    • (2000) Ther Drug Monit , vol.22 , pp. 14-19
    • Shaw, L.M.1    Kaplan, B.2    DeNofrio, D.3    Korecka, M.4    Brayman, K.L.5
  • 27
    • 0036148838 scopus 로고    scopus 로고
    • Monitoring of mycophenolic Acid in clinical transplantation
    • Shaw LM, Pawinski T, Korecka M, Nawrocki A. Monitoring of mycophenolic Acid in clinical transplantation. Ther Drug Monit 2002 ; 24 : 68-73.
    • (2002) Ther Drug Monit , vol.24 , pp. 68-73
    • Shaw, L.M.1    Pawinski, T.2    Korecka, M.3    Nawrocki, A.4
  • 28
    • 0032128447 scopus 로고    scopus 로고
    • Rapamycin: Distribution, pharmacokinetics and therapeutic range investigations: An update
    • Trepanier DJ, Gallant H, Legatt DF, Yatscoff RW. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update. Clin Biochem 1998 ; 31 : 345-51.
    • (1998) Clin Biochem , vol.31 , pp. 345-351
    • Trepanier, D.J.1    Gallant, H.2    Legatt, D.F.3    Yatscoff, R.W.4
  • 30
    • 0034121591 scopus 로고    scopus 로고
    • An immunoassay for the measurement of sirolimus
    • Jones K, Saadat-Lajevard S, Lee T, et al. An immunoassay for the measurement of sirolimus. Clin Ther 2000 ; 22 : B49-61.
    • (2000) Clin Ther , vol.22
    • Jones, K.1    Saadat-Lajevard, S.2    Lee, T.3
  • 31
    • 0034065402 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
    • MacDonald A, Scarola J, Burke JT, Zimmerman JJ. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 2000 ; 22 : B101-21.
    • (2000) Clin Ther , vol.22
    • MacDonald, A.1    Scarola, J.2    Burke, J.T.3    Zimmerman, J.J.4
  • 32
    • 0035956745 scopus 로고    scopus 로고
    • A worldwide, phase llI, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts
    • MacDonald AS. A worldwide, phase llI, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001 ; 71 : 271-80.
    • (2001) Transplantation , vol.71 , pp. 271-280
    • MacDonald, A.S.1
  • 33
    • 0034070977 scopus 로고    scopus 로고
    • Toxicity and efficacy of sirolimus: Relationship to whole-blood concentrations
    • Meier-Kriesche HU, Kaplan B. Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations. Clin Ther 2000 ; 22 : B93-100.
    • (2000) Clin Ther , vol.22
    • Meier-Kriesche, H.U.1    Kaplan, B.2
  • 34
    • 0034023846 scopus 로고    scopus 로고
    • Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation
    • Aspeslet LJ, Yatscoff RW. Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation. Clin Ther 2000 ; 22 : B86-92.
    • (2000) Clin Ther , vol.22
    • Aspeslet, L.J.1    Yatscoff, R.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.